| Saturday 5 April 2003 | ||
| Organizer | A. Semplicini (Padova, Italy) | |
| Sponsors | Neopharmed Takeda Merck, Sharp & Dohme Abbott Stroder Chiesi |
|
Cerebrovascular complications of hypertension: actual and future developments |
||
| Session I | ||
| Chairs | A.C. Pessina (Padova, Italy) & A. Lechi (Verona, Italy) | Abstract No. |
| 14.00 – 14.10 | Welcome and introduction: hard versus soft cerebrovascular end points in clinical trials A. Semplicini (Padova, Italy) |
|
| 14.10 – 14.30 | Hypertension and stroke: epidemiology and prevention C. Cuspidi (Milan, Italy) |
|
| 14.30 – 14.50 | Hypertension and stroke: epidemiology and prevention G. Leonetti (Milan, Italy) |
|
| Session II | Round table | |
| Chairs | P. Amodio (Padova, Italy) & G. Meneghetti (Padova, Italy) | |
| 14.50 – 15.10 | Neuropsychological testing in the early detection of cognitive dysfuntion in hypertension C.A. Umiltà (Padova, Italy) |
|
| 15.10 – 15.30 | US studies in the evaluation of the risk of developing vascular dementia N. Bornstein (Tel-Aviv, Israel) |
|
| 15.30 – 15.50 | Biochemical markers of cerebral ischaemia P. Madeddu and C. Emanueli (Sassari, Italy) |
|
| 15.50 – 16.10 | PET / SPET in the assessment of cerebral perfusion and metabolism A. Cagnin (Padova, Italy) |
|
| 16.10 – 16.20 | coffee break | |
| 16.20 – 16.40 | The neurophysiological tools in the assessment of early mental changes associated to severe hypertension G. Barrett (Fareham, UK) |
|
| 16.40 – 17.00 | Neuroimaging P. Scheltens (Amsterdam, The Netherlands) |
|
| 17.00 – 17.30 | Discussion | |
| 17.30 – 17.45 | Cognitive decline and diabetes type 1 F. Del Piccolo, D. Mapelli, A. Maran, C. Crepaldi, P. Amodio,and C. Umiltà (Padova, Italy) |
226 |
| 17.45 – 18.00 | Impaired cerebral vasoreactivity in hypertensives: an early marker of vascular dementia? A. Realdi, V. Mascagna, L. Ciccariello, L. Macchini, F. Del Piccolo, P. Amodio, D. Mapelli, A.M. Maresca, and A. Semplicini (Padua, Italy) |
227 |
| 18.00 | End of workshop | |
